Global Drugs and Diagnostics for Hematological Disorders

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Apr 5, 2017 at 12:00 PM 35

Global Drugs and Diagnostics for Hematological Disorders Markets, 2020

Dublin, April 05, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Drugs and Diagnostics for Hematological Disorders: Global Markets" report to their offering. The global market for hematology drugs and diagnostics is expected to grow from nearly $86.5 billion in 2015 to $124.3 billion in 2020 at a compound annual growth rate of 7.5% from 2015-2020. The scope of this study covers instruments, reagents, testing, screening technology and the therapeutics markets for hematological disorders, including hemophilia and blood cancers. The report also discusses the regulatory environment, current technologies, new technologies, hematological disorders and cancer incidence, market projections and market share, along with latest trends, and clinical and new developments.

This report provides: - An overview of the global market for drugs and diagnostics for hematological disorders. - Analyses of global market trends, with data from2015, and projections of CAGRs through 2020. - A breakdown of the market by hematological diseases, hematological cancers, and hematological diagnostics. - A review of blood cancers, such as various types of leukemia, lymphoma, and myeloma, and their therapies. - Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities - Delineation of drugs approved by the FDA for hematological disorders. - Profiles of key companies in the industry. Key Topics Covered: 1: Introduction - Study Goals And Objectives - Reasons For Doing This Study - Intended Audience - Scope Of The Study - Methodology - Information Sources 2: Summary 3: Hematalogical Disorders - Blood - Blood Disorders/Diseases 4: Hematological Cancers - Classic Classification 5: Leukemia - Lymphocytic Leukemias - Myelogenous Leukemias - Conclusions 6: Lymphoma - Overview - Non-Hodgkin Lymphoma - Lymphoma Treatment 7: Multiple Myeloma - Overview - Conclusions 8: Myelodysplastic Syndromes - Classes Of Mds - Diagnosis And Tests - Prognosis And Treatment Options - Drug Profiles - Conclusions 9: Myeloproliferative Disorders - Types Of Chronic Myeloproliferative Disorders - Stages Of Chronic Myeloproliferative Disorders - Diagnosis - Treatment - Polycythemia Vera - Chronic Idiopathic Myelofibrosis - Essential Thrombocythemia - Chronic Neutrophilic Leukemia - Chronic Eosinophilic Leukemia - Summary 10: Epidemiology Of Hematological Cancers - India - Kenya - Worldwide Incidence Of Blood Cancers - Leukemia - Lymphoma - Myeloma - Myelodysplastic Syndromes - Blood Diseases And Incidence - Bleeding Disorders 11: Hematology Instruments And Reagents: A Global Market Perspective - Hematological Malignancies - Market Dynamics: Hematology Instruments And Reagents - Hematology Test Products And Market - Conclusions 12: Global Market For Treatments For Hematological Disorders - Therapeutic Drug Market - Conclusions 13: Hematological Cancer Therapies Market - Overview - Hematological Cancers Drug Market - Classification Of Hematologic Malignancies - Global Cytotoxic Therapies Market - Leukemia Market And Challenges - Chronic Myelogenous Leukemia Market - Acute Lymphocytic Leukemia Market - Acute Myeloid Leukemia (Aml) Market - Chronic Lymphocytic Leukemia Market - Lymphoma Drug Market - Multiple Myeloma Treatment Market - Myelodysplastic Syndrome Market - Myeloproliferative Disorders - Market For Essential Thrombocytosis (Et) - Myelofibrosis Market - Polycythemia Vera (Pv) Therapeutics Market 14: Patent Landscape And Current Developments - Hematological Cancer Drug Patent Expiries - New Approvals 15: Selected Company Profiles - Abbott Laboratories - Abon Pharmaceuticals - Ambit Biosciences - Amgen - Amphastar Pharmaceuticals - Ariad Pharmaceuticals - Astellas Pharma Us - Astex Pharmaceuticals - Astrazeneca - Baxalta Inc. - Baxter Healthcare Corp. - Bayer Healthcare Pharmaceuticals - Biogen Idec - Boehringer Ingelheim Gmbh - Bristol-Myers Squibb - Celgene Corp. - Chugai Pharmaceutical - C.R. Bard - CZ Biomed Corp. - Daiichi Sankyo Co. Ltd. - Deciphera Pharmaceuticals - Diagnocure - Eisai Inc. - ELI Lilly And Co. - Enzon Pharmaceuticals - Erytech Pharma Sa - Exelixis - GE Healthcare - Genentech Inc. - Genmab Inc. - Gilead Sciences - Glaxosmithkline - Hologic - Horiba Ltd. - Johnson & Johnson - The Medicines Co. - Medkoo Biosciences - Momenta Pharmaceuticals - Noxxon Pharma Ag - Portola Pharmaceuticals Inc. - Opko Health - Otsuka Pharmaceutical - Pfizer - Pharmacyclics - Roche Diagnostics - Sandoz International Gmbh - Sanofi - Siemens AG - Spectrum Pharmaceuticals - Teva Pharmaceutical Industries Ltd. - Watson Pharmaceuticals Inc. - YM Biosciences Inc. For more information about this report visit http://www.researchandmarkets.com/research/kckpfz/drugs_and

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Diagnostics, Hematological Drugs

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Jari Spirits Set to Shake Up U.S. Market After Big Wins

Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...

NYSE Reflects on 9/11: Honoring Lives and Legacy

A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...

Fermi's Founder Pushes for Board Overhaul: What's Next?

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

2026 Buy-Side Index Reveals State Market Variance

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

High-Grade Copper Spurs Optimism for PolarX in Alaska

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...

Americas Cardroom's Poker Series Hits $7.2M Haul

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Lick the Plate Hits 2,000 Shows with Clown Band

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Supply Maverick Simplifies Global Shipping Processes

Paving the Way for Seamless International Shipping Supply Maverick's got a new mantra, folks: simplicity. They're slicing through the mess of international shipping and bringing some much-needed clarity for customers in Canada, Australia, and New Zealand. It’s about time someone shook up the logistics playbook. The Nuts and Bolts of the New Shipping System Imagine being...

Sustainability Investments: $17 Trillion Wager Faces Divergence

Sustainability Investments: A Tale of Contrasts In the world of sustainability, a staggering $17 trillion has been poured into technologies over the past decade. That’s no chump change. But what do we have to show for it? According to Bain & Company’s latest report, this massive financial injection hasn’t exactly hit a home run. Progress, much like the stock market...

Melissa Rivers Brings Her Wit Back to Emmys Carpet

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...